Inke S.A: APIs manufacturing plant.
01 1INKE, S.A.
02 1PCAS FINLAND OY
03 2Anonima Materie Sintetiche and Affini (AMSA) Spa
04 2AstraZeneca AB
05 2AstraZeneca Pharmaceuticals LP
06 1Cerbios-Pharma SA
07 1Fagron Inc
08 1Hainan Poly Pharm. Co., Ltd.
09 1Harman Finochem Limited
10 1LETCO MEDICAL, LLC
11 1Medisca Inc.
12 1Olon SpA
13 1Professional Compounding Centers of America dba PCCA
14 1Spectrum Laboratory Products, Inc.
15 1Suven Pharmaceuticals Limited
16 1Suven Pharmaceuticals Ltd
17 1Viyash Life Sciences Private Limited
01 3GLYCOPYRROLATE
02 1Glycopirronium Bromide
03 10Glycopyrrolate
04 1Glycopyrrolate Tosylate
05 1Glycopyrronium Tosylate Monohydrate
06 4Micronized Glycopyrronium Bromide
01 1China
02 1France
03 4India
04 3Italy
05 1Netherlands
06 1Spain
07 1Switzerland
08 3U.S.A
09 5United Kingdom
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0018
Start Marketing Date : 2017-07-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 51014-7146
Start Marketing Date : 2009-08-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17373-1035
Start Marketing Date : 2015-02-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17373-1036
Start Marketing Date : 2017-01-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 0310-0561
Start Marketing Date : 2022-09-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (68g/68g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0310-5600
Start Marketing Date : 2022-10-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (68g/68g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17228-4610
Start Marketing Date : 2022-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1188g/1188g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17228-5600
Start Marketing Date : 2022-10-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1188g/1188g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14335-250
Start Marketing Date : 2021-12-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0545
Start Marketing Date : 2017-03-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Glycopyrronium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glycopyrronium Bromide, including repackagers and relabelers. The FDA regulates Glycopyrronium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glycopyrronium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glycopyrronium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glycopyrronium Bromide supplier is an individual or a company that provides Glycopyrronium Bromide active pharmaceutical ingredient (API) or Glycopyrronium Bromide finished formulations upon request. The Glycopyrronium Bromide suppliers may include Glycopyrronium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Glycopyrronium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glycopyrronium Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glycopyrronium Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glycopyrronium Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glycopyrronium Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glycopyrronium Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glycopyrronium Bromide suppliers with NDC on PharmaCompass.
We have 15 companies offering Glycopyrronium Bromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
